Literature DB >> 18432951

Differentiation of peripheral blood monocytes into dendritic cells.

David W O'Neill1, Nina Bhardwaj.   

Abstract

Dendritic cells (DCs) are potent antigen-presenting cells (APC) that are important in the initiation and control of cellular immune responses. Commonly used in T cell-stimulation experiments, DCs are typically "matured" in vitro with microbial products or proinflammatory cytokines, and then loaded with antigens from any number of sources, including peptides, whole proteins, cell lysates, RNA, microbes, or killed tumor cells. This unit presents a simple and commonly used method for the generation of mature human dendritic cells--differentiating them from peripheral blood monocytes.

Entities:  

Mesh:

Year:  2005        PMID: 18432951     DOI: 10.1002/0471142735.im22f04s67

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  15 in total

Review 1.  Directing dendritic cell immunotherapy towards successful cancer treatment.

Authors:  Rachel Lubong Sabado; Nina Bhardwaj
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

2.  Immunosuppressive effects of the traditional Chinese herb Qu Mai on human alloreactive T cells.

Authors:  J Reid-Adam; N Yang; Y Song; P Cravedi; X-M Li; P Heeger
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

3.  TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.

Authors:  Dusan Bogunovic; Olivier Manches; Emmanuelle Godefroy; Alice Yewdall; Anne Gallois; Andres M Salazar; Isabelle Marie; David E Levy; Nina Bhardwaj
Journal:  Cancer Res       Date:  2011-07-05       Impact factor: 12.701

4.  CD8+ T cells produce a dialyzable antigen-specific activator of dendritic cells.

Authors:  Ian A Myles; Ming Zhao; Glenn Nardone; Lisa R Olano; Jensen D Reckhow; Danial Saleem; Timothy J Break; Michail S Lionakis; Timothy G Myers; Paul J Gardina; Charles H Kirkpatrick; Steven M Holland; Sandip K Datta
Journal:  J Leukoc Biol       Date:  2016-08-11       Impact factor: 4.962

Review 5.  Dendritic cell-based immunotherapy.

Authors:  Rachel L Sabado; Sreekumar Balan; Nina Bhardwaj
Journal:  Cell Res       Date:  2016-12-27       Impact factor: 25.617

6.  Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Authors:  Daniel Carapau; Robert Mitchell; Adéla Nacer; Alan Shaw; Caroline Othoro; Ute Frevert; Elizabeth Nardin
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Role of the NK cell-activating receptor CRACC in periodontitis.

Authors:  Benjamin Krämer; Moritz Kebschull; Michael Nowak; Ryan T Demmer; Manuela Haupt; Christian Körner; Sven Perner; Søren Jepsen; Jacob Nattermann; Panos N Papapanou
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

8.  Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells.

Authors:  Melissa Victoria Fernandez; Elizabeth Miller; Florian Krammer; Ramya Gopal; Benjamin D Greenbaum; Nina Bhardwaj
Journal:  J Leukoc Biol       Date:  2015-11-16       Impact factor: 4.962

9.  Activation and measurement of NLRP3 inflammasome activity using IL-1β in human monocyte-derived dendritic cells.

Authors:  Melissa V Fernandez; Elizabeth A Miller; Nina Bhardwaj
Journal:  J Vis Exp       Date:  2014-05-22       Impact factor: 1.355

10.  West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.

Authors:  S Kovats; S Turner; A Simmons; T Powe; E Chakravarty; J Alberola-Ila
Journal:  Clin Exp Immunol       Date:  2016-09-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.